MedTrace Logo

Real World COVID-19 Antiviral Effectiveness Research

NCT05638919 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660

Last updated 2023-05-23

No results posted yet for this study

Summary

This study is a prospective observational cohort study to evaluate the benefit of oral antivirals (nirmatrelvir plus ritonavir or molnupiravir) in Ministry of Health institutions. In this study, we will observe the progress of COVID-19 study participants seen in the health clinic up to 90 days from their initial visit to the health clinic.

Conditions

Interventions

DRUG

Oral Antiviral

Nirmatrelvir plus ritonavir or molnupiravir

Sponsors & Collaborators

  • Clinical Research Centre, Malaysia

    lead OTHER

Principal Investigators

  • Ee Vien Low, Ph.D. · Clinical Research Center, Malaysia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-06
Primary Completion
2023-07-30
Completion
2023-07-31
FDA Drug
Yes

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05638919 on ClinicalTrials.gov